Orexo: A transformative year
Redeye lowers somewhat the fair value per share of Orexo to SEK 59 (62). Although we expect revenues to stabilise, the new policy to have a positive impact, digital therapies to pick up and OX124 to show progress, investments will be needed. We would like to see more tangible signals about revenue growth.